ICU SeaStar Medical Holding Corp

Fundamentals / CIK 0001831868 / USD
Other share classes on CIK 0001831868: ICUCW

SeaStar Medical Holding Corp reported $2.17M in revenue and a net loss of $14.68M for the trailing twelve months ended September 30, 2026 (up 247.0% year over year), with a 92.6% gross margin and a -692.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ICU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$3.99M$1.99M$0-$24.63MFY 2021 Net Income: -$4.60M2021FY 2022 Net Income: -$12.19M2022FY 2023 Revenue: $0FY 2023 Net Income: -$26.23M2023FY 2024 Revenue: $135KFY 2024 Net Income: -$24.83M2024FY 2025 Revenue: $1.23MFY 2025 Net Income: -$12.15M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.23M $135K $0 -- --
Cost of Revenue $53K $0 $0 -- --
Gross Profit $1.18M $135K $0 -- --
Research & Development $7.52M $9.11M $5.97M $2.50M $2.77M
Total Operating Expenses $13.36M $17.98M $14.21M $11.61M $4.45M
Operating Income -$12.18M -$17.84M -$14.21M -$11.61M -$4.45M
Interest Income $325K $101K $0 -- $12K
Interest Expense $31K $244K $1.08M $630K $212K
Income Before Tax -$12.15M -$24.83M -$26.23M -$12.19M -$4.60M
Income Tax Expense $3.0K $3.0K $0 $1.0K -$1.0K
Net Income -$12.15M -$24.83M -$26.23M -$12.19M -$4.60M
Basic EPS -$5.86 -$66.33 -$302.60 -$370.00 -$157.50
Diluted EPS -- -$66.30 -$302.60 -$370.00 -$157.50
Basic Shares Outstanding 2.1M 374.4K 86.7K 32.8K 29.0K
Diluted Shares Outstanding -- 374.4K 86.7K 32.8K 29.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $635K $615K $495K $420K $183K $338K $293K $67K
Cost of Revenue $48K $54K $46K $12K $14K $27K $0 $0
Gross Profit $587K $561K $449K $408K $169K $311K $293K $67K
Research & Development $3.57M $2.52M $2.34M $2.20M $1.85M $1.04M $2.43M $2.74M
Total Operating Expenses $5.17M $4.35M $4.05M $3.42M $3.75M $2.07M $4.12M $4.83M
Operating Income -$4.58M -$3.79M -$3.60M -$3.02M -$3.58M -$1.76M -$3.82M -$4.77M
Interest Income $54K $69K $91K $125K $107K $45K $48K $19K
Interest Expense $2.0K $8.0K $6.0K $13K $0 $9.0K $11K -$253K
Income Before Tax -$4.53M -$3.73M -$3.52M -$2.90M -$3.47M -$2.00M -$3.77M -$4.42M
Income Tax Expense $0 $0 $3.0K $0 $0 $0 $3.0K $0
Net Income -$4.53M -$3.73M -$3.52M -$2.90M -$3.47M -$2.00M -$3.77M -$4.42M
Basic EPS -$1.03 -$0.91 -$0.90 -- -$1.30 -$1.77 -$4.38 --
Diluted EPS -- -- -- -- -- -$1.80 -$4.40 --
Basic Shares Outstanding 4.4M 4.1M 3.9M -- 2.7M 1.1M 861.8K --
Diluted Shares Outstanding -- -- -- -- -- 1.1M 861.8K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $11.98M $1.82M $176K $73K $13K $725K $47K $52K $38K
Cash & Short-Term Investments $11.98M $1.82M $176K $73K $13K $725K $47K $0 $0
Accounts Receivable, Net $237K $112K $0 -- -- -- -- -- --
Inventory $66K $0 -- -- -- -- -- -- --
Total Current Assets $13.58M $3.77M $2.31M $1.23M $1.23M $2.21M $1.52M $601K $269K
Other Non-Current Assets $578K $892K -- -- -- -- -- -- --
Total Non-Current Assets $578K $892K $1.21M $1.28M $1.36M $1.44M $1.52M $2.0K $0
Total Assets $14.16M $4.66M $3.51M $2.51M $2.60M $3.65M $3.04M $603K $269K
Accounts Payable $948K $3.05M $4.37M $5.04M $4.36M $3.02M $1.93M $85K --
Short-Term Debt -- $574K $565K -- $5.91M $493K $1.18M -- --
Deferred Revenue (Current) -- $0 $100K -- -- -- -- -- --
Total Current Liabilities $3.74M $6.84M $13.05M $12.80M $14.35M $21.28M $16.15M $3.12M $249K
Long-Term Debt -- -- $3.58M $5.72M -- $5.25M $6.47M -- --
Deferred Revenue (Non-Current) -- -- $0 -- -- -- -- -- --
Total Non-Current Liabilities $0 $0 $4.34M $5.72M $0 $5.75M $7.65M $299K $0
Total Liabilities $3.74M $6.84M $17.38M $18.52M $14.35M $27.02M $23.80M $3.42M $249K
Total Debt (incl. Leases) -- $574K $4.14M $5.72M $5.91M $5.75M $7.65M -- --
Common Stock $4.0K $2.0K $1.0K $3.0K $2.0K $1.0K $1.0K -- --
Retained Earnings -$151.7M -$139.6M -$114.7M -$105.3M -$98.05M -$95.60M -$88.50M -$76.31M -$5.2K
Total Stockholders' Equity $10.42M -$2.18M -$13.87M -$16.02M -$11.76M -$23.38M -$20.76M -$2.82M $1.77M
Total Equity $10.42M -$2.18M -$13.87M -$16.02M -$11.76M -$23.38M -$20.76M -$2.82M $1.77M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.99M $6.96M $9.35M $11.98M $13.76M $6.30M $5.30M $1.82M
Cash & Short-Term Investments $3.99M $6.96M $9.35M $11.98M $13.76M $6.30M $5.30M $1.82M
Accounts Receivable, Net $178K $208K $179K $237K $221K $217K $110K $112K
Inventory $45K $77K $57K $66K $83K $77K $44K $0
Total Current Assets $4.97M $8.23M $10.76M $13.58M $14.87M $7.65M $6.78M $3.77M
Other Non-Current Assets $343K $421K $499K $578K $656K -- -- $892K
Total Non-Current Assets $343K $421K $499K $578K $656K $736K $7.42M $892K
Total Assets $5.31M $8.65M $11.26M $14.16M $15.53M $8.38M $14.20M $4.66M
Accounts Payable $1.47M $750K $719K $948K $2.02M $3.16M $3.40M $3.05M
Short-Term Debt -- -- -- -- -- -- -- $574K
Deferred Revenue (Current) -- -- -- -- -- -- -- $0
Total Current Liabilities $4.84M $4.35M $3.95M $3.74M $4.07M $5.04M $7.03M $6.84M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $4.84M $4.35M $3.95M $3.74M $4.07M $5.04M $7.03M $6.84M
Total Debt (incl. Leases) -- -- -- -- -- -- -- $574K
Common Stock $4.0K $4.0K $4.0K $4.0K $3.0K $2.0K $2.0K $2.0K
Retained Earnings -$163.5M -$159.0M -$155.2M -$151.7M -$148.8M -$145.3M -$143.3M -$139.6M
Total Stockholders' Equity $469K $4.30M $7.32M $10.42M $11.46M $3.34M $565K -$2.18M
Total Equity $469K $4.30M $7.32M $10.42M $11.46M $3.34M $565K -$2.18M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.15M -$24.83M -$26.23M -$12.19M -$4.60M
Stock-Based Compensation $624K $887K $1.93M $1.31M $14K
Change in Receivables -$125K -$112K $0 -- --
Change in Inventory -$66K $0 -- $0 $55K
Change in Payables -$2.10M -$1.28M $2.44M $1.55M -$297K
Operating Cash Flow -$13.60M -$16.01M -$10.29M -$7.79M -$5.11M
Investing Cash Flow -- -- -- -- -$105.6M
Common Stock Issued $16.13M $17.44M $4.74M $0 --
Financing Cash Flow $23.76M $17.65M $10.41M $7.33M $2.82M
Net Change in Cash $10.16M $1.64M $129K -$463K -$2.30M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.53M -$3.73M -$3.52M -$2.90M -$3.47M -$2.00M -$3.77M -$4.42M
Stock-Based Compensation $163K -$99K $91K $70K $290K $97K $167K $212K
Change in Receivables $30K -$29K $58K -$16K -$4.0K -$107K $2.0K -$44K
Change in Inventory $32K -$20K $9.0K $17K -$6.0K -$33K -$44K $0
Change in Payables $717K $31K -$229K -$1.07M -$1.14M -$239K $351K -$423K
Operating Cash Flow -$3.37M -$2.99M -$2.76M -$4.09M -$3.84M -$3.01M -$2.65M -$4.69M
Common Stock Issued $539K $810K $329K $1.79M $9.18M $3.59M $1.57M $3.86M
Financing Cash Flow $403K $605K $129K $2.31M $11.30M $4.01M $6.13M $4.43M
Net Change in Cash -$2.97M -$2.39M -$2.63M -$1.78M $7.46M $1.01M $3.48M -$263K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 95.7% 100.0% -- -- --
Operating Margin -986.6% -13216.3% -- -- --
Net Profit Margin -984.6% -18392.6% -- -- --
Return on Equity (ROE) -116.6% -- -- -- --
Return on Assets (ROA) -85.8% -533.1% -746.7% -401.3% -762.2%
Current Ratio 3.63x 0.55x 0.18x 0.09x 0.19x
Quick Ratio 3.61x 0.55x 0.01x 0.00x 0.00x
Revenue Growth (YoY) +814.1% -- -- -- --
Gross Profit Growth (YoY) +774.8% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 92.6% 92.6% 93.1% 95.7% 95.3% 96.5% 100.0% 100.0%
Operating Margin -692.4% -816.6% -832.5% -986.5% -1580.5% -1932.2% -4138.8% -13216.3%
Net Profit Margin -678.2% -795.5% -828.6% -984.6% -1551.1% -1915.3% -3716.1% -18392.6%
Return on Equity (ROE) -3130.9% -317.2% -162.7% -116.6% -119.2% -439.1% -2815.0% --
Return on Assets (ROA) -276.5% -157.6% -105.6% -85.8% -88.0% -175.0% -112.0% -533.1%
Current Ratio 1.03x 1.89x 2.73x 3.63x 3.66x 1.52x 0.96x 0.55x
Quick Ratio 1.02x 1.87x 2.71x 3.61x 3.64x 1.50x 0.96x 0.55x
Revenue Growth (YoY) +247.0% +82.0% +68.9% +526.9% +169.1% -- -- --
Gross Profit Growth (YoY) +247.3% +80.4% +53.2% +509.0% +148.5% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001831868) · from December 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal